GRAL
Diagnostics & Research · Healthcare
CEO, Board Member
2026-01-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when GRAIL, Inc. publishes a filing, an earnings call transcript or a press release.
Get GRAL alertsJoshua Ofman is recorded as CEO at GRAIL, Inc. (GRAL) since June 1, 2026 and Board Member at GRAIL, Inc. (GRAL) since January 1, 2026. The newest filing on record that lists Joshua Ofman as Board Member at GRAIL, Inc. (GRAL) is dated April 28, 2026. The proxy statement of GRAIL, Inc. reports total compensation of $4,318,592 for Joshua Ofman in fiscal 2025, including a base salary of $655,000. Disclosed compensation is on record for 2 fiscal years. GRAIL, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at GRAIL, Inc. includes Dr. Joshua Ofman (CEO), Robert P. Ragusa (CEO and Board Member), Robert Ragusa (CEO and Board Member) and 7 others.
2026-06-01–present
2026-01-01–present
Last confirmed April 28, 2026
Source not stated
GRAL
Diagnostics & Research · Healthcare
CEO, Board Member
2026-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | GRAIL, Inc. (GRAL) | President | $655,000 | $4,318,592 |
| 2024 | GRAIL, Inc. (GRAL) | President | $655,000 | $5,806,255 |
No call appearances or filed executive changes recorded yet.